Literature DB >> 24003198

Creating transgenic shRNA mice by recombinase-mediated cassette exchange.

Prem K Premsrirut, Lukas E Dow, Youngkyu Park, Gregory J Hannon, Scott W Lowe.   

Abstract

RNA interference (RNAi) enables sequence-specific, experimentally induced silencing of virtually any gene by tapping into innate regulatory mechanisms that are conserved among most eukaryotes. The principles that enable transgenic RNAi in cell lines can also be used to create transgenic animals, which express short-hairpin RNAs (shRNAs) in a regulated or tissue-specific fashion. However, RNAi in transgenic animals is somewhat more challenging than RNAi in cultured cells. The activities of promoters that are commonly used for shRNA expression in cell culture can vary enormously in different tissues, and founder lines also typically vary in transgene expression due to the effects of their single integration sites. There are many ways to produce mice carrying shRNA transgenes and the method described here uses recombinase-mediated cassette exchange (RMCE). RMCE permits insertion of the shRNA transgene into a well-characterized locus that gives reproducible and predictable expression in each founder and enhances the probability of potent expression in many cell types. This procedure is more involved and complex than simple pronuclear injection, but if even a few shRNA mice are envisioned, for example, to probe the functions of several genes, the effort of setting up the processes outlined below are well worthwhile. Note that when creating a transgenic mouse, one should take care to use the most potent shRNA possible. As a rule of thumb, the sequence chosen should provide >90% knockdown when introduced into cultured cells at single copy (e.g., on retroviral infection at a multiplicity of ≤0.3).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24003198      PMCID: PMC4028064          DOI: 10.1101/pdb.prot077057

Source DB:  PubMed          Journal:  Cold Spring Harb Protoc        ISSN: 1559-6095


  3 in total

1.  Creating an miR30-based shRNA vector.

Authors:  Kenneth Chang; Krista Marran; Amy Valentine; Gregory J Hannon
Journal:  Cold Spring Harb Protoc       Date:  2013-07-01

2.  Packaging shRNA retroviruses.

Authors:  Kenneth Chang; Krista Marran; Amy Valentine; Gregory J Hannon
Journal:  Cold Spring Harb Protoc       Date:  2013-08-01

3.  Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells.

Authors:  Caroline Beard; Konrad Hochedlinger; Kathrin Plath; Anton Wutz; Rudolf Jaenisch
Journal:  Genesis       Date:  2006-01       Impact factor: 2.487

  3 in total
  5 in total

1.  Controlled re-activation of epigenetically silenced Tet promoter-driven transgene expression by targeted demethylation.

Authors:  Natascha Gödecke; Lisha Zha; Shawal Spencer; Sara Behme; Pamela Riemer; Michael Rehli; Hansjörg Hauser; Dagmar Wirth
Journal:  Nucleic Acids Res       Date:  2017-09-19       Impact factor: 16.971

2.  Systemic silencing of PHD2 causes reversible immune regulatory dysfunction.

Authors:  Atsushi Yamamoto; Joanna Hester; Philip S Macklin; Kento Kawai; Masateru Uchiyama; Daniel Biggs; Tammie Bishop; Katherine Bull; Xiaotong Cheng; Eleanor Cawthorne; Mathew L Coleman; Tanya L Crockford; Ben Davies; Lukas E Dow; Rob Goldin; Kamil Kranc; Hiromi Kudo; Hannah Lawson; James McAuliffe; Kate Milward; Cheryl L Scudamore; Elizabeth Soilleux; Fadi Issa; Peter J Ratcliffe; Chris W Pugh
Journal:  J Clin Invest       Date:  2019-06-04       Impact factor: 14.808

3.  Using the GEMM-ESC strategy to study gene function in mouse models.

Authors:  Ivo J Huijbers; Jessica Del Bravo; Rahmen Bin Ali; Colin Pritchard; Tanya M Braumuller; Martine H van Miltenburg; Linda Henneman; Ewa M Michalak; Anton Berns; Jos Jonkers
Journal:  Nat Protoc       Date:  2015-10-15       Impact factor: 13.491

Review 4.  Off and back-on again: a tumor suppressor's tale.

Authors:  Jonuelle Acosta; Walter Wang; David M Feldser
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

5.  Inducible in vivo silencing of Brd4 identifies potential toxicities of sustained BET protein inhibition.

Authors:  Jessica E Bolden; Nilgun Tasdemir; Lukas E Dow; Johan H van Es; John E Wilkinson; Zhen Zhao; Hans Clevers; Scott W Lowe
Journal:  Cell Rep       Date:  2014-09-18       Impact factor: 9.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.